Fundz

Mercy Bio Analytics, Inc. reported raising $27.3 Million in an initial SEC Form D filing, from an offering of $27.3 Million

PRIVATEFeb 01, 2021

Amount Raised

$27.3 Million

$27.3 Million sold, per SEC Form D (first sale Feb 1, 2021)

Round Type

Venture

WalthamBiotechnology

Quick answer

Mercy BioAnalytics raised $27.3 Million in a funding round, dated February 1, 2021. Mercy BioAnalytics is based in Waltham, Massachusetts, United States.

How much did Mercy BioAnalytics raise?
Mercy BioAnalytics raised $27.3 Million in a funding round on February 1, 2021.
What does Mercy BioAnalytics do?
Mercy BioAnalytics, Inc. is on a mission to relieve suffering and save lives through the early detection of cancer.
Where is Mercy BioAnalytics based and how big is it?
Mercy BioAnalytics is based in Waltham, Massachusetts, United States. Fundz records about 52 employees.
Who are the decision-makers at Mercy BioAnalytics?
Fundz holds 1 contact at Mercy BioAnalytics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Mercy BioAnalytics that raised within 45 days of this round, from Fundz verified event records.

  • Axe Compute Inc. raised $18M on March 18, 2021.
  • ClearIt LLC raised $310K (Seed) on March 18, 2021.
  • Cytonus Therapeutics, Inc. raised $2.5M (Seed) on March 18, 2021.
  • UroGen Pharma raised $75M (Grant) on March 18, 2021.
  • Inmedix raised $470K on March 18, 2021.
  • TriSalus Life Sciences raised $81M on March 18, 2021.

Who to call at Mercy BioAnalytics, and when

A new round usually means Mercy BioAnalytics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mercy BioAnalytics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mercy BioAnalytics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mercy BioAnalytics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mercy BioAnalytics

Location

880 Winter St Suite 2003

Waltham, Massachusetts, United States

About

Mercy BioAnalytics, Inc. is on a mission to relieve suffering and save lives through the early detection of cancer. Early-stage cancer is difficult to detect, but when found, is more often amenable to curative therapy. The patented Mercy Halo™ liquid biopsy platform utilizes biomarker co-localization to interrogate highly abundant, blood-based extracellular vesicles that carry unique cancer signatures from their parent cells. The Mercy Halo platform is designed to detect early-stage cancer, when it is most treatable, and enhance the quality of life for cancer patients and their families. Mercy's initial focus is the early detection of ovarian and lung cancers. Ovarian cancer, the most lethal gynecological cancer, typically goes undetected until it is too late to cure. Lung cancer, the number one cancer killer, takes more lives than breast and prostate cancers combined.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mercy BioAnalytics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Mercy BioAnalytics's next move

See what Strategic adds

Mercy BioAnalytics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.